Speed Medical results, Fiscal year 2023
Net profit, assets, equity and cash flow for Fiscal year 2023, against the same period a year earlier, from the published financial statements.
Net profit-49.01 millionEGP · +66.5% vs the same period a year earlier
Total assets566 millionEGP · −6.6% vs the same period a year earlier
Shareholders' equity232 millionEGP · −17.7% vs the same period a year earlier
Operating cash flow26.44 millionEGP · +168.0% vs the same period a year earlier
In short
- Speed Medical's net profit for Fiscal year 2023 was about -49.01 million EGP, up +66.5% from -146 million EGP in Fiscal year 2022.
- Total assets at the end of Fiscal year 2023 were about 566 million EGP, and shareholders' equity about 232 million EGP.
- Operating cash flow for Fiscal year 2023 was positive at 26.44 million EGP.
Key lines against the same period a year earlier
This periodFiscal year 2022Change
Net profit-49.01 million-146 million+66.5%
Gross profit-2.84 million13.28 million−121.4%
Total assets566 million606 million−6.6%
Total liabilities333 million324 million+3.0%
Shareholders' equity232 million282 million−17.7%
Total liabilities and equity566 million606 million−6.6%
Operating cash flow26.44 million9.87 million+168.0%
Investing cash flow-5.62 million-50.21 million+88.8%
Financing cash flow-21.04 million-53.87 million+61.0%
Net change in cash-211 thousand-94.21 million+99.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy